Scorpion Capital

Scorpion Capital Aug 15, 2025

Soleno Therapeutics SLNO

Scorpion shorts Soleno (SLNO), arguing VYKAT XR — a $500K/year repackaged 50-year-old generic — is causing pediatric heart-failure hospitalizations and was approved on sham trial data; the launch will collapse.

Scorpion Capital Jan 10, 2025

TransMedics Group Inc TMDX

TransMedics is a Medicare billing-fraud and kickback racket whose top transplant-center customers are fleeing as cheaper alternatives arrive — Scorpion sets a $0 target.

⌂ ◫ ” ⚑

Lasertec Corporation 6920

Lasertec, Japan's most actively traded stock at a $23B cap and 17x sales, is a textbook accounting fraud — a defective EUV tool, fake fab, and looming impairment will wipe out most earnings.

Lasertec Corporation 6920

Lasertec — Japan's most-traded stock at $23B — is inflating inventory to hide that its flagship ACTIS EUV mask-inspection tool is defective; a 65-70% writedown will erase 85% of retained earnings.

N5 V4 C4

⌂ ◫ ” ⚑

Lasertec Corporation 6920

Lasertec — Japan's most-traded stock at $23B market cap — is a colossal accounting fraud whose defective EUV mask-inspection tool and sham 'Innovation Park' mirror Olympus and Toshiba before collapse.

N4 V2 C1

Scorpion Capital Jan 14, 2024

Lasertec Corporation 6920

Lasertec, hailed as 'Japan's ASML,' is a $23B accounting fraud — a textbook inventory scheme masking a defective EUV tool destined for a 65-70% write-down reminiscent of Olympus and Toshiba.

N5 V2 C1

”

TransMedics TMDX

Scorpion petitions the FDA to suspend TransMedics' OCS Liver approval, citing pervasive off-label use, necrotic-organ device failures, and an alleged systematic cover-up of safety issues from regulators.

N4 V1 C1

⚑

Scorpion Capital Apr 03, 2023

Harmony Biosciences HRMY

Scorpion petitions the FDA to pull Wakix (pitolisant), arguing the H3-receptor drug is inherently cardiotoxic, clinically inferior to $10 modafinil, and approved on fraud-tainted Russian trials.

N4 V1 C1

Scorpion Capital Mar 28, 2023

Harmony Biosciences Holdings HRMY

Scorpion shorts HRMY: Wakix is a toxic, ineffective H3 antagonist propped up by sham foreign trials, an Insys-style kickback scheme, and off-label sales — collapse is imminent.

Scorpion Capital Nov 15, 2022

Twist Bioscience TWST

Twist is a textbook Ponzi — price-dumping commodity DNA below cost, inventing a fake 'DNA chip,' masking negative gross margins via WorldCom-style accounting fraud. Target: $0.

Scorpion Capital May 03, 2022

IonQ Inc. IONQ

IonQ's 32-qubit 'world's most powerful quantum computer' is a Nikola-style hoax; its only real machine can't reliably add 1+1, and revenue stems from sham related-party deals.

Scorpion Capital Oct 06, 2021

Ginkgo Bioworks DNA

Ginkgo Bioworks is a $23B SPAC fraud whose foundry 'customers' are related-party shells that round-trip cash back as phantom revenue — a US 'China Hustle' headed for a Zymergen-style collapse.

Scorpion Capital Sep 15, 2021

Berkeley Lights BLI

Berkeley Lights' $2M Beacon is a flow-cytometer knockoff customers call a clunker; with flat sales, fleeing insiders, and 50x-cheaper rivals, Scorpion pegs BLI at $0.

N5 V3 C3

Scorpion Capital Apr 15, 2021

QuantumScape QS

QuantumScape is a $15B SPAC whose solid-state battery breakthrough is a Theranos-grade mirage; 15 experts say the science is not there and the April 24 lockup expiry will trigger an insider dump.

N5 V2 C2

Scorpion Capital Jan 07, 2021

Nevro Corp. NVRO

Nevro is a failed one-trick pony at 15x sales: the pivotal SENZA trial was rigged, HF10 is a phony premise, explant rates run 22-33%, and kickbacks prop up what remains of sales.